Market Overview:
The global clinical nutritional supplements market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, growing geriatric population, and rising awareness about the benefits of clinical nutritional supplements. Based on type, the liquid supplements segment is expected to account for the largest share of the global clinical nutritional supplements market in 2018. This segment is projected to grow at a CAGR of 7.0% from 2018 to 2030 due to its ease-of-use and convenience.
Product Definition:
Clinical nutritional supplements are products that are intended to supplement the diet and which have been shown in clinical studies to provide health benefits. The use of clinical nutritional supplements is becoming more common as people become more interested in taking steps to improve their health. Clinical nutritional supplements can offer a variety of health benefits, including improving overall wellness, boosting energy levels, helping to manage weight, and preventing chronic diseases.
Liquid Supplements:
Liquid nutritional supplements are those products that are consumed in a drink or a soft gel and can be mixed with other drinks. They have higher absorption rates than tablets and capsules, which makes them more effective. The market for liquid nutritional supplements is growing at a rapid rate due to factors such as increasing health awareness among consumers, the aging population, changing food habits of people along with an increase in diseases like diabetes and obesity across the globe.
Semi-Solid Supplements:
Semi-solid nutraceuticals are nutritional supplements that can be consumed in liquid or soft gel form. These products have a low melting point and therefore can be easily incorporated into various food & beverage products. Semi-solid nutraceuticals are used as additives to enhance the nutritional content of food & beverages, pharmaceuticals, and personal care products such as shampoos and soaps.
Application Insights:
The global clinical nutritional supplements market is segmented by application into adult, paediatric and geriatric. The adult application segment held the largest share in 2017 owing to the rising prevalence of diseases such as cardiovascular, cancer and diabetes among adults. Moreover, increasing awareness about maintaining a healthy lifestyle through regular exercise and diet management has increased the demand for clinical nutrition supplements among adults worldwide.
The growing incidence of obesity has created a significant demand for weight management products across all age groups of people including infants & children. Increasing consumption of energy drinks along with soft drinks is one of the major reasons behind this rise in obesity cases globally; thus leading to an increase in product demand from 2018 to 2030.
Protein deficiency is common amongst patients suffering from chronic kidney disease (CKD) or dialysis due to low protein intake resulting in reduced muscle mass.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to rising awareness among people regarding a healthy lifestyle and increasing disposable income, which enables people to choose from various nutritional products available in the market. Asia Pacific is anticipated to witness significant growth over the next eight years owing to growing health concerns among consumers coupled with improving healthcare infrastructure and economic development in emerging countries such as China, India, Thailand, Singapore and Indonesia will drive demand for nutritional supplements over this period.
The European market has been witnessing high demand for dietary supplements due to an increase in consumer awareness about health issues associated with a poor diet including lack of nutrients on one hand.
Growth Factors:
- Increasing awareness about the benefits of clinical nutritional supplements among consumers.
- Rising incidence of chronic diseases and disorders that can be managed with clinical nutritional supplements.
- Growing demand for preventive healthcare measures, which is driving the uptake of clinical nutritional supplements.
- Proliferation of online retail channels for selling these products, making them more easily accessible to consumers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Nutritional Supplements Market Research Report
By Type
Liquid Supplements, Semi-Solid Supplements, Powder Supplements
By Application
Paediatric, Adult, Geriatric
By Companies
Medline Industries, Baxter, B. Braun Melsungen, Fresenius Kabi, Otsuka Pharmaceutical, Abbott Laboratories, Nutricia, GlaxoSmithKline, Pfizer, Perrigo, Nature’s Bounty, Victus, Cambrooke Therapeutics, Bayer, Sichuan Kelun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Nutritional Supplements Market Report Segments:
The global Clinical Nutritional Supplements market is segmented on the basis of:
Types
Liquid Supplements, Semi-Solid Supplements, Powder Supplements
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Paediatric, Adult, Geriatric
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medline Industries
- Baxter
- B. Braun Melsungen
- Fresenius Kabi
- Otsuka Pharmaceutical
- Abbott Laboratories
- Nutricia
- GlaxoSmithKline
- Pfizer
- Perrigo
- Nature’s Bounty
- Victus
- Cambrooke Therapeutics
- Bayer
- Sichuan Kelun Pharmaceutical
Highlights of The Clinical Nutritional Supplements Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Supplements
- Semi-Solid Supplements
- Powder Supplements
- By Application:
- Paediatric
- Adult
- Geriatric
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Nutritional Supplements Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical nutritional supplements are products that are intended to supplement the diet and improve health. They may contain vitamins, minerals, herbs, or other substances intended to support general health and well-being.
Some of the key players operating in the clinical nutritional supplements market are Medline Industries, Baxter, B. Braun Melsungen, Fresenius Kabi, Otsuka Pharmaceutical, Abbott Laboratories, Nutricia, GlaxoSmithKline, Pfizer, Perrigo, Nature’s Bounty, Victus, Cambrooke Therapeutics, Bayer, Sichuan Kelun Pharmaceutical.
The clinical nutritional supplements market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Nutritional Supplements Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Nutritional Supplements Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Nutritional Supplements Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Nutritional Supplements Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Nutritional Supplements Market Size & Forecast, 2018-2028
4.5.1 Clinical Nutritional Supplements Market Size and Y-o-Y Growth
4.5.2 Clinical Nutritional Supplements Market Absolute $ Opportunity
Chapter 5 Global Clinical Nutritional Supplements Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Nutritional Supplements Market Size Forecast by Type
5.2.1 Liquid Supplements
5.2.2 Semi-Solid Supplements
5.2.3 Powder Supplements
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Nutritional Supplements Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Nutritional Supplements Market Size Forecast by Applications
6.2.1 Paediatric
6.2.2 Adult
6.2.3 Geriatric
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Nutritional Supplements Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Nutritional Supplements Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Nutritional Supplements Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Nutritional Supplements Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Nutritional Supplements Market Size Forecast by Type
9.6.1 Liquid Supplements
9.6.2 Semi-Solid Supplements
9.6.3 Powder Supplements
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Nutritional Supplements Market Size Forecast by Applications
9.10.1 Paediatric
9.10.2 Adult
9.10.3 Geriatric
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Nutritional Supplements Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Nutritional Supplements Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Nutritional Supplements Market Size Forecast by Type
10.6.1 Liquid Supplements
10.6.2 Semi-Solid Supplements
10.6.3 Powder Supplements
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Nutritional Supplements Market Size Forecast by Applications
10.10.1 Paediatric
10.10.2 Adult
10.10.3 Geriatric
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Nutritional Supplements Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Nutritional Supplements Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Nutritional Supplements Market Size Forecast by Type
11.6.1 Liquid Supplements
11.6.2 Semi-Solid Supplements
11.6.3 Powder Supplements
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Nutritional Supplements Market Size Forecast by Applications
11.10.1 Paediatric
11.10.2 Adult
11.10.3 Geriatric
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Nutritional Supplements Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Nutritional Supplements Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Nutritional Supplements Market Size Forecast by Type
12.6.1 Liquid Supplements
12.6.2 Semi-Solid Supplements
12.6.3 Powder Supplements
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Nutritional Supplements Market Size Forecast by Applications
12.10.1 Paediatric
12.10.2 Adult
12.10.3 Geriatric
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Nutritional Supplements Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Nutritional Supplements Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Nutritional Supplements Market Size Forecast by Type
13.6.1 Liquid Supplements
13.6.2 Semi-Solid Supplements
13.6.3 Powder Supplements
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Nutritional Supplements Market Size Forecast by Applications
13.10.1 Paediatric
13.10.2 Adult
13.10.3 Geriatric
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Nutritional Supplements Market: Competitive Dashboard
14.2 Global Clinical Nutritional Supplements Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medline Industries
14.3.2 Baxter
14.3.3 B. Braun Melsungen
14.3.4 Fresenius Kabi
14.3.5 Otsuka Pharmaceutical
14.3.6 Abbott Laboratories
14.3.7 Nutricia
14.3.8 GlaxoSmithKline
14.3.9 Pfizer
14.3.10 Perrigo
14.3.11 Nature’s Bounty
14.3.12 Victus
14.3.13 Cambrooke Therapeutics
14.3.14 Bayer
14.3.15 Sichuan Kelun Pharmaceutical
